These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3658353)

  • 1. Improving the therapeutic index of topical phenylephrine by reducing drop volume.
    Brown RH; Wood TS; Lynch MG; Schoenwald RD; Chien DS; Jennings LW
    Ophthalmology; 1987 Jul; 94(7):847-50. PubMed ID: 3658353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of reduced eyedrop size and eyelid closure on the therapeutic index of phenylephrine.
    Whitson JT; Love R; Brown RH; Lynch MG; Schoenwald RD
    Am J Ophthalmol; 1993 Mar; 115(3):357-9. PubMed ID: 8442496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of phenylephrine drop size in infants achieves equal dilation with decreased systemic absorption.
    Lynch MG; Brown RH; Goode SM; Schoenwald RD; Chien DS
    Arch Ophthalmol; 1987 Oct; 105(10):1364-5. PubMed ID: 3662909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A combination solution for routine pupillary dilation.
    Krumholz DM; Portello JK; Rosenfield M; Rosenbaum JD
    Optometry; 2006 Jul; 77(7):350-3. PubMed ID: 16814239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ocular gelfoam disc-applicator for pupillary dilation in humans.
    Negvesky GJ; Butrus SI; Abifarah HA; Lee YC; Yalkowsky SH
    J Ocul Pharmacol Ther; 2000 Aug; 16(4):311-5. PubMed ID: 10977126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-precision piezo-ejection ocular microdosing: Phase II study on local and systemic effects of topical phenylephrine.
    Ianchulev T; Weinreb R; Tsai JC; Lin S; Pasquale LR
    Ther Deliv; 2018 Jan; 9(1):17-27. PubMed ID: 29076771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aqueous vs viscous phenylephrine. I. Systemic absorption and cardiovascular effects.
    Kumar V; Schoenwald RD; Barcellos WA; Chien DS; Folk JC; Weingeist TA
    Arch Ophthalmol; 1986 Aug; 104(8):1189-91. PubMed ID: 3741249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pupillary dilatation with single eyedrop mydriatic combinations.
    Apt L; Henrick A
    Am J Ophthalmol; 1980 Apr; 89(4):553-9. PubMed ID: 7369319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac effects of different eyedrop preparations of timolol in rabbits.
    Järvinen K; Urtti A
    Curr Eye Res; 1992 May; 11(5):469-73. PubMed ID: 1606842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic absorption and cardiovascular effects of phenylephrine eyedrops.
    Kumar V; Schoenwald RD; Chien DS; Packer AJ; Choi WW
    Am J Ophthalmol; 1985 Feb; 99(2):180-4. PubMed ID: 3970123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo comparison of phenylephrine and phenylephrine oxazolidine instilled in the monkey eye.
    Schoenwald RD; Folk JC; Kumar V; Piper JG
    J Ocul Pharmacol; 1987; 3(4):333-40. PubMed ID: 3503921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of an eye drop mixture for pupillary dilatation: A randomized comparative study.
    Bhurayanontachai P; Saengkaew S; Apiromruck P
    J Optom; 2017; 10(2):111-116. PubMed ID: 27321772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorometric determination of phenylephrine hydrochloride by liquid chromatography in human plasma.
    Chien DS; Schoenwald RD
    J Pharm Sci; 1985 May; 74(5):562-4. PubMed ID: 4020635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desired pupillary dilation achieved with a smaller drop volume of phenylephrine in rabbits.
    Lal A; Sharma ML
    Indian J Physiol Pharmacol; 1992 Apr; 36(2):141-2. PubMed ID: 1506083
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine.
    Kyyrönen K; Urtti A
    Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1827-33. PubMed ID: 2211028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mydriatic and cardiovascular effects of phenylephrine 2.5% versus phenylephrine 10%, both associated with tropicamide 1%.
    Motta MM; Coblentz J; Fernandes BF; Burnier MN
    Ophthalmic Res; 2009; 42(2):87-9. PubMed ID: 19478547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of commercial dilating agents on laser flare-cell measurements.
    Chin PK; Cuzzani OE; Gimbel HV; Sun R
    Can J Ophthalmol; 1996 Dec; 31(7):362-5. PubMed ID: 8971457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of Pupillary Dilation on Intraocular Pressure and Anterior Segment Morphology in Subjects with and without Pseudoexfoliation.
    Atalay E; Tamçelik N; Cicik ME
    Curr Eye Res; 2015 May; 40(6):646-52. PubMed ID: 25197765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pupil dilation using phenylephrine alone or in combination with tropicamide.
    Eyeson-Annan ML; Hirst LW; Battistutta D; Green A
    Ophthalmology; 1998 Apr; 105(4):726-32. PubMed ID: 9544648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of topical application of phenylephrine hydrochloride on hyperplastic gingivitis.
    Pernsteiner CL; Ash MM
    J Periodontol; 1977 Aug; 48(8):473-7. PubMed ID: 333082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.